LNP-CTNNB1

N/A

Report date: 2023/12/28 17:25:54

Base Information

Drug NameLNP-CTNNB1
Drug Alias NameCTNNB1-siRNACTNNB1-LNPLNP-CTNNB1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals IncUniversity Of Pittsburgh School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh School Of Medicine
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A